Top Section
Top Section
Executive is moving to more senior role
India is on track for a record year of IPOs. Global tech giants continue to plough capital into a fast-growing consumer economy that is investing heavily in ensuring it’s a major player — along with the US and China — in an AI-first world
◆ Deal finds demand despite arrest of South Korea's president ◆ High single digit concession left for investors ◆ Leads added spread to calm concerns
More articles
More articles
More articles
-
HSBC’s former Asia Pacific leveraged and acquisition finance head Lyndon Hsu is understood to be heading to Standard Chartered to lead its levfin business. -
It has been a long time coming but Indonesia has finally regained its investment grade status from all three major ratings agencies, after S&P boosted the sovereign’s rating to BBB- from BB+ with a stable outlook on May 19.
-
China National Chemical Corp (ChemChina) defied any jitters caused by Moody’s downgrade of China’s sovereign on Wednesday, pricing a senior perpetual bond. The only dollar debt issuer to brave the market, the state-owned company’s strong following helped it price inside fair value, said bankers.
-
Reliance Infrastructure has received the final go ahead from India’s market regulator to list its infrastructure investment fund, putting it on track to be the country’s third InvIT IPO.
-
Block deals are being printed in Asia with a vengeance this year, with follow-on activity already double that of IPOs. In the past few weeks, successive overnight bookbuilds and IPOs kept bankers busy as stocks hit record highs. Barring a major upset, the gravy train looks set to continue, writes John Loh.
-
WuXi Biologics’ HK$3.9bn ($510.4m) IPO is off to a resounding start, with books multiple times covered within hours of opening on Thursday, according to bankers close to the deal.
shared comment list
